Overview
- 95 inspections across 82 sites are on record.
- 316 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-15.
At a glance
Inspections
95
Sites
82
Observations
316
Career since
Mar 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Bright Cell Inc | 15 May 2026 | Biologics | On file |
| GVS TM, Inc | 1 May 2026 | Biologics | On file |
| Dendreon Pharmaceuticals LLC | 25 Mar 2026 | Biologics | On file |
| Biomat USA, Incorporated | 18 Feb 2026 | Biologics | On file |
| George E Wahlen VA Medical Center Transfusion Service MC113 | 9 Jan 2026 | Biologics |
Sites inspected
Bright Cell IncIrvine, United States1 insp.
GVS TM, IncCovina, United States1 insp.
Dendreon Pharmaceuticals LLCSeal Beach, United States1 insp.
Biomat USA, IncorporatedTaylorsville, United States1 insp.
George E Wahlen VA Medical Center Transfusion Service MC113Salt Lake City, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Laurissa S Flowers7 shared
Matthew J Gretkierewicz5 shared
Kelly D Moore5 shared
Dylan R Jock3 shared
Creighton T Tuzon3 shared
William F Lagud3 shared
Deepa E Vadakkan2 shared
Maurine Fadlalla2 shared
Richard L Bartlett2 shared
Celeta S Coves2 shared
Full investigator report
Get the verbatim findings behind Emily B Camire's 316 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site